TPA Table    body {font-family: 'Open Sans', sans-serif;}

### TPA and Neuraxial Block

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

| Minimal Time between  
last dose and  
neuraxial procedure | Can it be given with  
epidural catheter in place? | Restart after  
neuraxial procedure and/or  
catheter insertion | Restart after  
catheter removal |
| --- | --- | --- | --- |
| Avoid  
Insufficient clear data  
  
Consider assessing clotting  
studies and fibrinogen  
at 48 hours after last dose.  
  
Other source: 48 hours | No | Insufficient data.  
Not until fibrinogen level has recovered.  
  
Other source:  
10 days without catheter | Insufficient data.  
Not until fibrinogen  
level has recovered.  
  
Other source:  
No sooner than 10  
days after initial dose |

  
**Deep plexus and peripheral blocks:** Same recommendations as neuraxial.**Superficial peripheral blocks:** Based on vascularity, site compressibility and available management if bleeding occurred.**  
  
Labs  
**Plasma fibrinogen level  
PT and aPTT  
  
Always refer to the latest ASRA (American Society of Regional Anesthesia and Pain) Recommendations  
https://www.asra.com/advisory-guidelines  
  
ASRA Assistance:  
Toll free in US: 855-795-ASRA (2772)  
412-471-2718  
asraassistant@asra.com